Pharma Co. Beats Shareholder Suit Over Migraine Drug
Zosano Pharma Corp. has beaten claims that it lied to investors about the development of a migraine drug called Qtrypta, with a California federal judge finding that the shareholders did not...To view the full article, register now.
Already a subscriber? Click here to view full article